Epidemiology and Antimicrobial Resistance of Stenotrophomonas maltophilia in China, 2014–2021
Infectious Diseases and Therapy · 2025-01 · 14 (1) · 261-274
DOI: 10.1007/s40121-024-01099-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infectious Diseases and Therapy, online erschienen am 28.12.2024. Verfasst von Hanli Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, The First Affiliated Hospital of Wannan Medical College, No 2 Zheshan West Road, Wuhu, 241000, Anhui, China. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: the Special Research Start-up Fund for Recruited Talent of the First Affiliated Hospital of Wannan Medical College, Key Research Project of Anhui Provincial Health Commission.
Abstract (Originalsprache)
INTRODUCTION: Stenotrophomonas maltophilia is an opportunistic pathogen associated with various nosocomial infections and is known for its intrinsic multidrug resistance. This study aims to provide a comprehensive overview of the epidemiology and resistance patterns of S. maltophilia in China from 2014 to 2021. METHODS: Data were extracted from the China Antimicrobial Resistance Surveillance System (CARSS) and the Blood Bacterial Resistance Investigation Collaborative System (BRICS), encompassing 1412 medical institutions across 31 provinces in China. We analyzed the prevalence of S. maltophilia in clinical isolates, focusing on specific patient populations and departments, as well as resistance profiles to recommended first-line antibiotics, including sulfamethoxazole-trimethoprim, levofloxacin, and minocycline. RESULTS: A total of 514,768 S. maltophilia strains were analyzed. The overall prevalence of S. maltophilia among all clinical bacterial isolates remained stable at approximately 2.1%, with higher rates observed in intensive care units and elderly patients. Resistance rates to sulfamethoxazole-trimethoprim decreased from 9.8% in 2014 to 7.5% in 2021. In contrast, resistance to levofloxacin showed a slight upward trend, increasing from 8.5% in 2014 to 9.5% in 2021. Meanwhile, minocycline resistance remained low, fluctuating marginally from 2.7% in 2014 to 1.7% in 2021. CONCLUSIONS: This study highlights the stable prevalence of S. maltophilia in clinical settings in China and the overall low resistance rates to recommended first-line antibiotics. However, alarmingly high resistance rates were observed in specific specimen types, particularly in blood cultures, suggesting that minocycline may be the only reliable therapeutic option among the six tested antibiotics for treating such infections in China. Continuous surveillance and effective infection control measures are essential to manage S. maltophilia infections, particularly in vulnerable populations. Future research should focus on measuring the true burden of these infections and monitoring the susceptibility of the newly introduced antibiotics, such as cefiderocol.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory Medicine, The First Affiliated Hospital of Wannan Medical College, No 2 Zheshan West Road, Wuhu, 241000, Anhui, China.
- Pulmonary and Critical Care Department, The Second People's Hospital of Wuhu, No. 259 Jiuhua Middle Road, Wuhu, 241000, Anhui, China.
- Xi'an Jiaotong-Liverpool University, No. 111 Ren'ai Road, SuZhou, 215000, Jiangsu, China.
- Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, No. 218 Jixi Road, Hefei, 230022, Anhui, China.
- Department of Respiratory Medicine, The First Affiliated Hospital of Wannan Medical College, No 2 Zheshan West Road, Wuhu, 241000, Anhui, China. chengyusheng@yjsyy.com.
- Department of Respiratory Medicine, The First Affiliated Hospital of Wannan Medical College, No 2 Zheshan West Road, Wuhu, 241000, Anhui, China. zhalei@yjsyy.com.
Förderung
- the Special Research Start-up Fund for Recruited Talent of the First Affiliated Hospital of Wannan Medical College
- Key Research Project of Anhui Provincial Health Commission
Zitieren
APA
Wang, H., Li, S., Ji, H., Hu, Y., Zhou, S., Chen, X., Lu, Z., You, Q., Cheng, Y., & Zha, L. (2025). Epidemiology and Antimicrobial Resistance of Stenotrophomonas maltophilia in China, 2014–2021. Infectious Diseases and Therapy, 14(1), 261-274. https://doi.org/10.1007/s40121-024-01099-7
Vancouver
Wang H, Li S, Ji H, Hu Y, Zhou S, Chen X, et al. Epidemiology and Antimicrobial Resistance of Stenotrophomonas maltophilia in China, 2014–2021. Infectious Diseases and Therapy. 2025;14(1):261-274. doi:10.1007/s40121-024-01099-7
BibTeX
@article{Wang2025,
author = {Wang, Hanli and Li, Shirong and Ji, Haoyu and Hu, Yixin and Zhou, Susheng and Chen, Xingwu and Lu, Zhiwei and You, Qinghai and Cheng, Yusheng and Zha, Lei},
title = {Epidemiology and Antimicrobial Resistance of Stenotrophomonas maltophilia in China, 2014–2021},
journal = {Infectious Diseases and Therapy},
year = {2025},
volume = {14},
number = {1},
pages = {261--274},
doi = {10.1007/s40121-024-01099-7}
}
EUVIMED